Current treatment strategies for cystic fibrosis

Research output: Contribution to journalReview article

Abstract

Strategies to prevent and aggressively treat pulmonary infection have led to dramatic gains in life expectancy for patients with cystic fibrosis. The author reviews these and newer therapies that target the disease's basic genetic defect and its pathophysiologic sequelae.

Original languageEnglish (US)
Pages (from-to)42-46+48
JournalIM - Internal Medicine
Volume17
Issue number10
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Inborn Genetic Diseases
Life Expectancy
Cystic Fibrosis
Lung
Infection
Therapeutics

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

@article{30253d29918544d3968d40f8b2f7b095,
title = "Current treatment strategies for cystic fibrosis",
abstract = "Strategies to prevent and aggressively treat pulmonary infection have led to dramatic gains in life expectancy for patients with cystic fibrosis. The author reviews these and newer therapies that target the disease's basic genetic defect and its pathophysiologic sequelae.",
author = "Stanley Fiel",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
volume = "17",
pages = "42--46+48",
journal = "IM - Internal Medicine",
issn = "1056-9286",
publisher = "Advanstar Communications",
number = "10",

}

Current treatment strategies for cystic fibrosis. / Fiel, Stanley.

In: IM - Internal Medicine, Vol. 17, No. 10, 01.01.1996, p. 42-46+48.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Current treatment strategies for cystic fibrosis

AU - Fiel, Stanley

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Strategies to prevent and aggressively treat pulmonary infection have led to dramatic gains in life expectancy for patients with cystic fibrosis. The author reviews these and newer therapies that target the disease's basic genetic defect and its pathophysiologic sequelae.

AB - Strategies to prevent and aggressively treat pulmonary infection have led to dramatic gains in life expectancy for patients with cystic fibrosis. The author reviews these and newer therapies that target the disease's basic genetic defect and its pathophysiologic sequelae.

UR - http://www.scopus.com/inward/record.url?scp=0029825475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029825475&partnerID=8YFLogxK

M3 - Review article

VL - 17

SP - 42-46+48

JO - IM - Internal Medicine

JF - IM - Internal Medicine

SN - 1056-9286

IS - 10

ER -